About Medicamen Biotech Ltd
Medicamen Biotech is engaged in Generic Finished Dosage Forms, Oncology Formulations and Research & Development services to cater to the needs of the Global Pharmaceuticals Industry.
Founded
1993
CEO
Rahul Bishnoi
Employees
609
HQ
New Delhi, New Delhi
Finished Products
1Sales
₹320.20Cr2Other Operating Income
₹2.22Cr3Other Trading Sales
₹1.43CrRaw Materials
1Raw Materials consumed
₹174.15Cr2Packing material
₹19.42Cr3Samples
₹-0.04CrAbout Medicamen Biotech Ltd
Medicamen Biotech is engaged in Generic Finished Dosage Forms, Oncology Formulations and Research & Development services to cater to the needs of the Global Pharmaceuticals Industry.
Founded:1993
CEO:Rahul Bishnoi
Employees:609
HQ:New Delhi, New Delhi
Finished Products
1Sales
₹320.20Cr2Other Operating Income
₹2.22Cr3Other Trading Sales
₹1.43CrRaw Materials
1Raw Materials consumed
₹174.15Cr2Packing material
₹19.42Cr3Samples
₹-0.04CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹448
52W Low
₹212
Volume74.79K
Avg VolumeN/A
Beta0.97
Dividend Yield0.38%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
35.61x
Valuation
P/B Ratio
1.30x
Valuation
EPS
₹7.40
Valuation
Dividend Yield
0.38%
Valuation
ROE
3.50%
Profitability
ROCE
4.79%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.17x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.